Carbamazepine drug reaction involving high fevers during the COVID-19 era

• Main Authors: Reuben Heyman-Kantor, MD (Author), Matthew Perez, MD (Author), Arti Phatak, PharmD, BCPS (Author), Danielle L. Anderson, MD (Author)
• Format: Book
• Published: American Association of Psychiatric Pharmacists, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Carbamazepine has demonstrated anticonvulsant properties and is used for a variety of indications in psychiatry and neurology. Total daily doses typically range from 200 to 1200 mg/d, generally divided into 2 doses. Carbamazepine has a broad side-effect profile but is not typically thought to produc...